Vanda Pharmaceuticals (VNDA) Cash from Financing Activities (2010 - 2026)
Vanda Pharmaceuticals recorded quarterly Cash from Financing Activities of -$776000.0 in Q1 2026, down 21.25% quarter-over-quarter from -$640000.0 in Q4 2025, and up 41.39% year-over-year from -$548837.6 in Q1 2025.
Vanda Pharmaceuticals' Cash from Financing Activities history runs 15 years deep, the most recent figure standing at -$776000.0 for Q1 2026.
- In Q1 2026, Cash from Financing Activities rose 41.39% year-over-year to -$776000.0; the TTM figure through Mar 2026 stood at -$2.4 million (down 59.43% YoY), while the FY2025 annual figure was -$2.9 million, down 1774.84% from the prior year.
- Cash from Financing Activities came in at -$776000.0 for Q1 2026 at Vanda Pharmaceuticals, down from -$640000.0 in the prior quarter.
- In the past five years, Cash from Financing Activities ranged from a high of $605000.0 in Q4 2022 to a low of -$1.3 million in Q1 2025.
- A 4-year average of -$344777.8 and a median of -$425000.0 in 2025 frame the typical range for Cash from Financing Activities.
- Across the five-year window, Cash from Financing Activities sank 312.9% in 2025 and soared 41.39% in 2026, its largest moves.
- Vanda Pharmaceuticals' Cash from Financing Activities stood at $605000.0 in 2022, then slumped by 125.62% to -$155000.0 in 2024, then tumbled by 312.9% to -$640000.0 in 2025, then retreated by 21.25% to -$776000.0 in 2026.
- According to Business Quant data, Cash from Financing Activities over the past three periods registered -$776000.0, -$640000.0, and -$517000.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 7.00 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -600,000.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 53,000.00 |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -538.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -802.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 15.71 Mn |
| 10 | Vanda Pharmaceuticals | 379.35 Mn | 177.04 Mn | 48.56 Mn | -776,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -776,000.00 |
| Mar 31, 2026 | -776,000.00 |
| Dec 31, 2025 | -640,000.00 |
| Dec 31, 2025 | -640,000.00 |
| Sep 30, 2025 | -517,000.00 |
| Sep 30, 2025 | -517,000.00 |
| Jun 30, 2025 | -425,000.00 |
| Jun 30, 2025 | -425,000.00 |
| Mar 31, 2025 | -1.32 Mn |
| Mar 31, 2025 | -1.32 Mn |
| Dec 31, 2024 | -155,000.00 |
| Dec 31, 2024 | -155,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Dec 31, 2022 | 605,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Sep 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Jun 30, 2022 | 125,000.00 |
| Dec 31, 2021 | 1.04 Mn |
| Dec 31, 2021 | 1.04 Mn |
| Sep 30, 2021 | 371,000.00 |
| Sep 30, 2021 | 371,000.00 |
| Jun 30, 2021 | 289,000.00 |
| Jun 30, 2021 | 289,000.00 |
| Mar 31, 2021 | 1.85 Mn |
| Mar 31, 2021 | 1.85 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Dec 31, 2020 | 1.43 Mn |
| Sep 30, 2020 | 123,000.00 |
| Sep 30, 2020 | 123,000.00 |
| Jun 30, 2020 | 3.60 Mn |
| Jun 30, 2020 | 3.60 Mn |
| Mar 31, 2020 | 479,000.00 |
| Mar 31, 2020 | 479,000.00 |
| Dec 31, 2019 | 2.12 Mn |
| Dec 31, 2019 | 2.12 Mn |
| Sep 30, 2019 | 558,000.00 |
| Sep 30, 2019 | 558,000.00 |
| Jun 30, 2019 | 3.41 Mn |
| Jun 30, 2019 | 3.41 Mn |
| Mar 31, 2019 | 179,000.00 |
| Mar 31, 2019 | 179,000.00 |
| Dec 31, 2018 | 792,000.00 |
| Dec 31, 2018 | 792,000.00 |
| Sep 30, 2018 | 112,000.00 |
| Sep 30, 2018 | 112,000.00 |
| Jun 30, 2018 | 2.49 Mn |
| Jun 30, 2018 | 2.49 Mn |
| Mar 31, 2018 | 103.73 Mn |
| Mar 31, 2018 | 103.73 Mn |
| Dec 31, 2017 | 81,000.00 |
| Dec 31, 2017 | 81,000.00 |
| Sep 30, 2017 | 768,000.00 |
| Sep 30, 2017 | 768,000.00 |
| Jun 30, 2017 | 2.19 Mn |
| Jun 30, 2017 | 2.19 Mn |
| Mar 31, 2017 | 2.21 Mn |
| Mar 31, 2017 | 2.21 Mn |
| Dec 31, 2016 | 750,000.00 |
| Dec 31, 2016 | 750,000.00 |
| Sep 30, 2016 | 5.96 Mn |
| Sep 30, 2016 | 5.96 Mn |
| Jun 30, 2016 | 1.02 Mn |
| Jun 30, 2016 | 1.02 Mn |
| Mar 31, 2016 | 24,000.00 |
| Mar 31, 2016 | 24,000.00 |
| Dec 31, 2015 | -1,000.00 |
| Dec 31, 2015 | -1,000.00 |
| Sep 30, 2015 | 3.58 Mn |
| Sep 30, 2015 | 3.58 Mn |
| Jun 30, 2015 | 592,000.00 |
| Jun 30, 2015 | 592,000.00 |
| Mar 31, 2015 | -79,000.00 |
| Mar 31, 2015 | -79,000.00 |
| Dec 31, 2014 | 87.49 Mn |
| Dec 31, 2014 | 87.49 Mn |
| Sep 30, 2014 | 198,000.00 |
| Sep 30, 2014 | 198,000.00 |
| Jun 30, 2014 | 32,000.00 |
| Jun 30, 2014 | 32,000.00 |
| Mar 31, 2014 | 2.01 Mn |
| Mar 31, 2014 | 2.01 Mn |
| Dec 31, 2013 | 441,000.00 |
| Dec 31, 2013 | 441,000.00 |
| Sep 30, 2013 | 48.82 Mn |
| Sep 30, 2013 | 48.82 Mn |
| Jun 30, 2013 | 794,000.00 |
| Jun 30, 2013 | 794,000.00 |
| Mar 31, 2013 | -193,000.00 |
| Mar 31, 2013 | -193,000.00 |
| Dec 31, 2011 | 20,000.00 |
| Dec 31, 2011 | 20,000.00 |
| Dec 31, 2010 | 1.35 Mn |
| Dec 31, 2010 | 1.35 Mn |
| Sep 30, 2010 | 42,000.00 |
| Sep 30, 2010 | 42,000.00 |